Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $70,794.85 -0.95%
Ethereum $2,089.74 -1.91%
BNB $655.19 -0.63%
Optimism $0.12 +0.97%
Arbitrum $0.10 -0.30%
Solana $88.17 -1.99%
Polygon $0.22 +2.77%
Cosmos $1.86 +0.38%
Avalanche $9.71 -1.47%

Bitcoin $70,794.85 -0.95%
Ethereum $2,089.74 -1.91%
BNB $655.19 -0.63%
Optimism $0.12 +0.97%
Arbitrum $0.10 -0.30%
Solana $88.17 -1.99%
Polygon $0.22 +2.77%
Cosmos $1.86 +0.38%
Avalanche $9.71 -1.47%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B